
Loading, please wait...

Loading, please wait...

Syndactyly stands as the most common congenital condition affecting the upper extremities. While many cases appear as part of a genetic syndrome, others occur sporadically. Recent medical research has focused on the nonsyndromic syndactyly cancer risk among pediatric populations. This investigation aimed to determine if children with this hand deformity face a higher likelihood of developing benign or malignant neoplasms compared to healthy peers.
Researchers utilized the TriNetX US Collaborative database to conduct a comprehensive retrospective analysis. They identified 7,478 patients aged ten years or younger who were diagnosed with syndactyly. To ensure accuracy, the team matched these patients 1:1 with controls based on age, sex, race, and ethnicity. Furthermore, they excluded patients with known congenital malformation syndromes to focus strictly on nonsyndromic cases. They then tracked the subsequent rate of neoplasms across both cohorts over several years.
The study results revealed a significant association between the physical phenotype and certain types of cancer. Specifically, patients in the syndactyly cohort showed a significantly higher rate of digestive malignancies than those in the control group. Moreover, investigators observed that the rate of benign neoplasms became statistically significant at the five-year follow-up mark. In contrast, the data did not show a significant difference during the first year or the one-to-five-year interval. Consequently, this suggests that the risk profile may evolve as the child grows.
Similarly, the incidence of "any neoplasm" followed a matching trend, becoming significant only after five years of follow-up. These findings indicate that while the immediate risk is low, long-term monitoring may be necessary. Currently, the biological mechanisms linking limb development to digestive tract oncology remain unclear. Therefore, researchers emphasize that further investigation is essential to understand the underlying genetic or developmental relationship between syndactyly and malignancy.
Research indicates that children with nonsyndromic syndactyly may have a higher rate of digestive malignancies and benign neoplasms, particularly noticeable after five years of follow-up.
While the study shows an increased statistical rate, the absolute risk remains a subject of ongoing research. Parents should maintain regular pediatric check-ups and discuss any concerns regarding long-term health with their specialist.
This specific study focused on nonsyndromic syndactyly. Cases associated with known genetic syndromes often have their own distinct sets of risks and surveillance guidelines.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Smith KL et al. Syndactyly and Risk of Cancer. Hand (N Y). 2026 Mar 09. doi: 10.1177/15589447261416115. PMID: 41797684.
Schraw JM, et al. Congenital anomalies and risk of childhood cancer: A population-based case-control study. Cancer. 2019;125(22):4020-4027.
Situm M, et al. Malignant Tumors of the Hand. Coll Antropol. 2014;38(1):315-320.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study links nonsyndromic syndactyly in children to an increased risk of digestive malignancies and benign neoplasms at a 5-year follow-up period....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today